New drug combo aims to shrink tumors before cancer surgery
NCT ID NCT04848116
Summary
This study is testing whether giving two immunotherapy drugs before surgery is safe and can help shrink tumors in people with head and neck cancer. The drugs, nivolumab and BMS-986253, aim to boost the body's immune system to attack the cancer. Researchers will see if this approach leads to better long-term results after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.